- Home
- YMAB vs BYRN Comparison
YMAB vs BYRN Comparison
Compare YMAB & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- BYRN
- Stock Information
- Founded
- YMAB 2015
- BYRN 2005
- Country
- YMAB United States
- BYRN United States
- Employees
- YMAB N/A
- BYRN N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- BYRN Industrial Machinery/Components
- Sector
- YMAB Health Care
- BYRN Miscellaneous
- Exchange
- YMAB Nasdaq
- BYRN Nasdaq
- Market Cap
- YMAB 482.4M
- BYRN 422.4M
- IPO Year
- YMAB 2018
- BYRN N/A
- Fundamental
- Price
- YMAB $9.38
- BYRN $27.08
- Analyst Decision
- YMAB Strong Buy
- BYRN Strong Buy
- Analyst Count
- YMAB 10
- BYRN 3
- Target Price
- YMAB $21.00
- BYRN $17.75
- AVG Volume (30 Days)
- YMAB 243.1K
- BYRN 590.2K
- Earning Date
- YMAB 11-08-2024
- BYRN 10-09-2024
- Dividend Yield
- YMAB N/A
- BYRN N/A
- EPS Growth
- YMAB N/A
- BYRN N/A
- EPS
- YMAB N/A
- BYRN 0.10
- Revenue
- YMAB $84,553,000.00
- BYRN $73,417,000.00
- Revenue This Year
- YMAB $6.46
- BYRN $104.84
- Revenue Next Year
- YMAB $20.68
- BYRN $29.23
- P/E Ratio
- YMAB N/A
- BYRN $268.34
- Revenue Growth
- YMAB N/A
- BYRN 70.65
- 52 Week Low
- YMAB $6.09
- BYRN $5.36
- 52 Week High
- YMAB $20.90
- BYRN $27.39
- Technical
- Relative Strength Index (RSI)
- YMAB 32.17
- BYRN 76.43
- Support Level
- YMAB $9.31
- BYRN $18.24
- Resistance Level
- YMAB $11.10
- BYRN $25.49
- Average True Range (ATR)
- YMAB 0.72
- BYRN 1.66
- MACD
- YMAB -0.00
- BYRN 0.73
- Stochastic Oscillator
- YMAB 3.87
- BYRN 98.87
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia and Canada.